DLH will pioneer medical and healthcare technology innovations for veterans

DLH Holdings Corp.

ATLANTA, Oct. 06, 2022 (GLOBE NEWSWIRE) — DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of innovative health research services and solutions to federal agencies, today announced that it has been awarded an Indefinite Delivery/Indefinite Quantity (ID/IQ) multi-award contract to strengthen the efforts of the Department of Veterans Affairs (“VA”) to design, develop, and test healthcare innovations.

Under the Accelerating VA Innovation and Learning (“AVAIL”) contract, DLH will compete with 17 primary winners for individual task orders across five task categories: Personalized Healthcare, Data Transformation, Digital Care, Immersive Technology (extended reality solutions) and delivery of care and services. The multi-award contract consists of a five-year base term and has a cap of $650 million, in aggregate, for all awardees. Specific values ​​will be assigned to contractors as task orders are completed and awarded.

“Ensuring veterans have access to the highest quality care is core to DLH’s mission, and this contract enables our company to connect AV with emerging tools, advanced processes, digital solutions and data transformation needed to support their long tradition as a pioneer in medical innovation,” said Jackie Everett, Chief Growth Officer of DLH. “DLH will leverage our expertise in applied research, genomics, synthetic data modeling, augmented and virtual reality, digital health tools and synthetic data modeling to support the design, development and testing of the next generation of medical devices needed by the AV as it accelerates its pace of modernization.

“We are honored by this opportunity to build on our long-standing relationship with the Department of Veterans Affairs, one of the nation’s key drivers of medical innovation,” added Zach Parker, President and CEO of DLH. “Under this contract, DLH can apply our digital transformation capabilities – covering artificial intelligence and machine learning, big data analytics, telehealth, modeling and simulation, etc. – to improve solutions advancements available to veterans, clinicians and caregivers.”

About DLH
DLH (NASDAQ: DLHC) provides improved health and preparedness solutions for federal programs through research, systems development and innovative care processes. The company’s experts in public health, performance assessment and health operations solve the complex problems facing civilian and military customers, leveraging digital transformation, artificial intelligence, advanced analytics, cloud-based applications, telehealth systems, and more. With more than 2,400 employees dedicated to the idea that “Your mission is our passion”, DLH brings a unique combination of experience in the government sector, a proven methodology and an unwavering commitment to public health to improve the lives of millions. of people. For more information, visit www.DLHcorp.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:
This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or the future financial performance of DLH. Any statements that refer to expectations, projections or other characterizations of future events or circumstances or that are not statements of historical fact (including, without limitation, statements that the Company or its direction “believes”, “expects”, “anticipates”, “plans”, “intentions” and similar expressions) should be considered forward-looking statements that involve risks and uncertainties that could cause actual events or DLH’s actual results will differ materially from those indicated by the forward-looking statements. Forward-looking statements in this release include, but are not limited to, statements regarding estimates of future revenue, operating profit, earnings and cash flow. These statements reflect our beliefs and assumptions about future events which may not prove to be accurate. Our actual results may differ materially from those forward-looking statements made in this release due to a variety of factors, including: the outbreak of the novel coronavirus (“COVID-19”), including measures to reduce its spread, and its impact on the economy and demand for our services are uncertain, unpredictable and may precipitate or exacerbate other risks and uncertainties; the risk that we may not realize the anticipated benefits of acquisitions; the challenges of managing larger and more extensive operations; contract awards under re-competition for current business and/or competition for new business; compliance with new banking, financial and other covenants; changes in customer budget priorities; government procurement (such as bid and award challenges, small business set asides, loss of work due to organizational conflicts of interest, etc.) and termination risks; the ability to successfully integrate acquisition transactions; the impact of inflation and higher interest rates; and other risks described in our filings with the SEC. For a discussion of such risks and uncertainties that could cause actual results to differ from those contained in the forward-looking statements, see “Risk Factors” in the Company’s periodic reports filed with the SEC, including our Annual Report. on Form 10-K for the fiscal year ended September 30, 2021, as well as subsequent reports filed thereafter. The forward-looking statements contained herein are not historical facts, but rather are based on current expectations, estimates, assumptions and projections regarding our industry and our business.
These forward-looking statements are made as of the date hereof and may become outdated over time. The Company assumes no responsibility to update forward-looking statements, except as required by law.

INVESTOR RELATIONS
Contact: Chris Witty
Phone: 646-438-9385
Email: [email protected]

Comments are closed.